Arrhythmogenic mitral valve prolapse—a systematic review of ventricular arrhythmia and sudden cardiac death outcomes before and after mitral valve surgery
Journal of Arrhythmia · 2025-08 · 41 (4)
DOI: 10.1002/joa3.70108 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Arrhythmia, online erschienen am 15.07.2025. Verfasst von James N Cameron und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Austin Health Melbourne Victoria Australia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott Fund, Medtronic, Bayer.
Abstract (Originalsprache)
Background
Several autopsy and observational studies have investigated the link between mitral valve prolapse (MVP) and sudden cardiac death (SCD) given the well accepted yet rare occurrence of ventricular arrhythmias (VA). Whether surgical intervention for arrhythmogenic MVP (aMVP) reduces VA and SCD risk remains unknown.
Methods
A systematic literature review was conducted using the PubMed database in December 2024. Studies documented in English were included if patients had undergone mitral valve (MV) surgery (MVS; repair or replacement) for MVP with documented rates of VA or SCD pre‐ and postintervention.
Results
Sixteen identified studies (8 cohort and 8 case studies) comprised 1233 patients (receiving medical or surgical treatment) with a pooled mean age of 61.5 years and 41.9% being female. A total of 657 MVP patients underwent MVS. Seven cohort studies reported rates of VA pre‐ and postintervention, with six of these and all case studies reporting a significant reduction. The remaining cohort study reported a reduction in SCD.
Conclusions
This systematic review indicates a reduction in VA following current guideline‐directed MVS for MVP. However, a residual risk of VA and SCD may remain postintervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology Austin Health Melbourne Victoria Australia.
- Faculty of Medicine, Dentistry and Health Sciences University of Melbourne Melbourne Victoria Australia.
- Department of Cardiology Northern Health Melbourne Victoria Australia.
- Victorian Heart Institute Monash University Clayton Victoria Australia.
- Adelaide Medical School University of Adelaide Adelaide South Australia Australia.
- Lyell McEwin Hospital Northern Adelaide Health Local Health Network Elizabeth Vale South Australia Australia.
ORCID-Profile: James N Cameron, Avi Sabbag, Prashanthan Sanders
Förderung
- Abbott Fund
- Medtronic
- Bayer
- Biotronik
- Pfizer
- Boston Scientific Corporation
Zitieren
APA
Cameron, J. N., Sutherland, N., Chow, C. L., Han, H. C., Yudi, M., Mahajan, R., Ganesan, A., Sabbag, A., Haugaa, K. H., Raman, J., Sanders, P., Farouque, O., & Lim, H. S. (2025). Arrhythmogenic mitral valve prolapse—a systematic review of ventricular arrhythmia and sudden cardiac death outcomes before and after mitral valve surgery. Journal of Arrhythmia, 41(4). https://doi.org/10.1002/joa3.70108
Vancouver
Cameron JN, Sutherland N, Chow CL, Han HC, Yudi M, Mahajan R, et al. Arrhythmogenic mitral valve prolapse—a systematic review of ventricular arrhythmia and sudden cardiac death outcomes before and after mitral valve surgery. Journal of Arrhythmia. 2025;41(4). doi:10.1002/joa3.70108
BibTeX
@article{Cameron2025,
author = {Cameron, James N and Sutherland, Nigel and Chow, Chee Loong and Han, Hui-Chen and Yudi, Matias and Mahajan, Rajiv and Ganesan, Anand and Sabbag, Avi and Haugaa, Kristina H and Raman, Jai and Sanders, Prashanthan and Farouque, Omar and Lim, Han S},
title = {Arrhythmogenic mitral valve prolapse—a systematic review of ventricular arrhythmia and sudden cardiac death outcomes before and after mitral valve surgery},
journal = {Journal of Arrhythmia},
year = {2025},
volume = {41},
number = {4},
doi = {10.1002/joa3.70108}
}
EUVIMED